1. Zhang Shuang., Li Zhan-Tao., Liu Man., Wang Jing-Ru., Xu Mei-Qi., Li Zhuo-Yue., Duan Xiao-Chuan., Hao Yan-Li., Zheng Xiu-Chai., Li Hui., Feng Zhen-Han., Zhang Xuan*.(2019). Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells. J Control Release, 295, 102-117. (IF=11.467) 2. Yang Xin., Wang Yifan., Chen Si., Zhang Shuang*., Cui Chunying*.(2021). Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors. Int J Nanomedicine, 16, 7051-7069.(IF=7.033) 3. Wang Yifan., Chen Si., Yang Xin., Zhang Shuang*., Cui Chunying*.(2021). Preparation Optimization of Bovine Serum Albumin Nanoparticles and Its Application for siRNA Delivery. Drug Des Devel Ther, 15, 1531-1547.(IF=3.033) 4. Zheng Xiu-Chai., Ren Wei., Zhang Shuang., Zhong Ting., Duan Xiao-Chuan., Yin Yi-Fan., Xu Mei-Qi., Hao Yan-Li., Li Zhan-Tao., Li Hui., Liu Man., Li Zhuo-Yue., Zhang Xuan*.(2018). The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles. Int J Nanomedicine, 13, 1495-1504. (IF=7.033) 5. 张爽; 张烜; 低分子肝素-抗肿瘤药物静电复合物纳米系统的制备方法及应用, 2018-5-30, 中国, 201810535496.0.(专利) |